名家匯(300506.SZ):實控人擬協議轉讓7.9384%的股份予顧顯濤
格隆匯 10 月 21日丨名家匯(300506.SZ)公佈,公司控股股東、實際控制人程宗玉為歸還股票質押融資貸款,擬將其持有的公司5200萬股股份協議轉讓給顧顯濤,佔公司總股本的7.9384%。
此次權益變動前,公司控股股東、實際控制人程宗玉直接持有公司223,670,096股股份,佔公司總股本的34.15%。此次權益變動後,程宗玉持有公司171,670,096股股份,佔公司總股本的26.21%,仍為公司控股股東、實際控制人。
此次權益變動前,顧顯濤未持有公司股份。此次權益變動後,顧顯濤持有公司5200萬股股份,佔公司總股本的7.9384%,成為公司持股5%以上股東。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.